MasterCraft Boat amends restated corporate bylaws
MasterCraft Boat Holdings filed its Fifth Amended and Restated Bylaws to establish updated corporate governance rules. This routine regulatory update outlines meeting procedures an…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
MasterCraft Boat Holdings filed its Fifth Amended and Restated Bylaws to establish updated corporate governance rules. This routine regulatory update outlines meeting procedures an…
The Federal Reserve and other agencies released a list identifying nonmetropolitan middle-income geographies that are distressed or underserved. This action aims to support access …
The company regained compliance with Nasdaq's bid price rule after completing a mandatory one-for-six reverse stock split. This reinstatement is subject to a monitoring period thro…
Moleculin Biotech has filed an exhibit with the SEC, usually containing supplementary information such as a press release. Investors should review this document for specific corpor…
USRC and Akebia halted the VOICE trial due to improved safety outcomes with Vafseo compared to ESAs. The interim data indicates a significant reduction in hospitalizations, support…
Vivani Medical Inc. filed an amended and restated 2022 omnibus incentive plan to authorize grants of stock awards to officers and directors. This governance update ensures the comp…
Monopar Therapeutics received Rare Pediatric Disease designation for ALXN1840 treating Wilson disease. This grants potential eligibility for a Pediatric Priority Review Voucher upo…
Novocure's Optune Pax device received a CE Mark for locally advanced pancreatic cancer supported by significant overall survival improvements in the PANOVA-3 trial. This regulatory…
The FDA has selected seven companies for the new PreCheck Pilot Program to strengthen domestic drug manufacturing and supply chain resilience. This initiative aims to boost America…
Plum Acquisition Corp. IV has rescheduled its extraordinary general meeting from July 2 to July 10, 2026. The postponement also extends the redemption deadline to July 8, giving sh…
TerrAscend Corp. filed a preliminary proxy statement for a Special Meeting voting on a 5-to-20 share consolidation ratio. The move is intended to allow the cannabis operator to sat…
High Roller Technologies announced its subsidiary ROLR US LLC received regulatory approval from the National Futures Association to launch prediction markets. This milestone grants…
DBV Technologies anticipates filing its Biologics License Application for the VIASKIN Peanut Patch in children aged 4 through 7 years in Q3 2026. The company received guidance to r…
Synergy CHC Corp. filed to amend its 2024 Equity Incentive Plan, raising the share pool to 150 million shares and granting the board authority to modify outstanding awards without …
WinVest Acquisition Corp.'s legal counsel BCRG Group confirms its agreement with the disclosure statements made in the June 23, 2026 Form 8-K. This validation supports compliance w…
NRC Health filed its First Amended and Restated Certificate of Incorporation with the Delaware Secretary of State, restating the company's capital structure. This administrative up…
The submitting entities filed a Form 8-K current report with the SEC, disclosing administrative address details and corporate registration information.
Replimune announced fiscal 2026 financial results and confirmed the FDA accepted its resubmission of the BLA for RP1 in combination with nivolumab for advanced melanoma with a goal…
Neurogene announced 30-month data showing participants significantly gained developmental milestones without plateauing or loss, demonstrating a durable therapeutic effect. This po…
Barrel Energy Inc. filed an exhibit (3.1) to amend a designation of preferred stock. The specific terms of the amendment were not visible in the provided file header.